The trading volume of these stocks is deviating from the norm in today's session.
Sanara Medtech Inc SMTI
$33.86
▼ -0.59%
($-0.20)
🎈 Low Float
🗓️ Earnings Next Week
Open
$33.62
Prev Close
$34.06
Day Range
$33.62 – $34.00
52W Range
$16.05 – $35.95
Market Cap
$310.29M
Beta
1.14
EPS (TTM)
$-3.88
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 1994-04-07 |
| Shares Out. | 9,190,000 |
| Website | sanaramedtech.com/ ↗ |
| Phone | 18175292300 |
| Employees | 108 |
| Revenue | $27.8M |
| Gross Profit | $25.9M |
| Net Income | $458,603 |
| Free Cash Flow | $3.4M |
| Total Assets | $69.3M |
| Total Liabilities | $62.3M |
| Equity | $7.0M |
About Sanara Medtech Inc
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.
Sanara Medtech Inc is a publicly traded company under the ticker symbol SMTI on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
9 analysts (2026-07-01)